Not applicableActive Not RecruitingNCT04993625
What this trial is testing
Selective Avoidance of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy In HER-2 Positive/Triple Negative Breast Cancer Patients With Excellent Radiologic Response to the Breast and Axilla, Prospective, Multi-center, Single-arm (ASLAN) Study
Who this might be right for
Breast Cancer
Jeong Eon Lee 178